Daiwa Securities Group Inc. Teva Pharmaceutical Industries LTD Transaction History

Daiwa Securities Group Inc.

  • $22.4 Billion
  • Q4 2024

A detailed history of Daiwa Securities Group Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 92,965 shares of TEVA stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
92,965
Previous 89,465 3.91%
Holding current value
$1.51 Million
Previous $1.61 Million 27.11%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$16.43 - $22.77 $57,505 - $79,695
3,500 Added 3.91%
92,965 $2.05 Million
Q3 2024

Nov 12, 2024
BUY
$15.81 - $18.96 $128,061 - $153,576
8,100 Added 9.96%
89,465 $1.61 Million
Q2 2024

Aug 07, 2024
SELL
$12.78 - $17.4 $438,711 - $597,307
-34,328 Reduced 29.67%
81,365 $1.32 Million
Q1 2024

May 02, 2024
BUY
$10.67 - $14.43 $44,493 - $60,173
4,170 Added 3.74%
115,693 $1.63 Million
Q4 2023

Jan 31, 2024
SELL
$8.12 - $10.63 $113,038 - $147,980
-13,921 Reduced 11.1%
111,523 $1.17 Million
Q3 2023

Nov 01, 2023
SELL
$7.48 - $10.7 $5,669 - $8,110
-758 Reduced 0.6%
125,444 $1.28 Million
Q2 2023

Jul 31, 2023
SELL
$7.2 - $9.47 $26,244 - $34,518
-3,645 Reduced 2.81%
126,202 $951,000
Q1 2023

May 02, 2023
BUY
$8.36 - $11.37 $100,595 - $136,815
12,033 Added 10.21%
129,847 $1.15 Million
Q4 2022

Feb 06, 2023
SELL
$7.95 - $9.48 $19,167 - $22,856
-2,411 Reduced 2.01%
117,814 $1.08 Million
Q3 2022

Nov 02, 2022
SELL
$6.86 - $11.95 $120,900 - $210,606
-17,624 Reduced 12.79%
120,225 $971,000
Q2 2022

Aug 09, 2022
SELL
$7.38 - $10.4 $128,751 - $181,438
-17,446 Reduced 11.23%
137,849 $1.04 Million
Q1 2022

Apr 29, 2022
BUY
$7.33 - $9.39 $137,019 - $175,527
18,693 Added 13.68%
155,295 $1.46 Million
Q4 2021

Feb 03, 2022
SELL
$7.9 - $10.19 $87,318 - $112,630
-11,053 Reduced 7.49%
136,602 $1.1 Million
Q3 2021

Nov 05, 2021
BUY
$8.38 - $10.18 $98,490 - $119,645
11,753 Added 8.65%
147,655 $1.44 Million
Q2 2021

Aug 06, 2021
BUY
$9.9 - $11.56 $92,367 - $107,854
9,330 Added 7.37%
135,902 $1.35 Million
Q1 2021

May 03, 2021
SELL
$10.34 - $12.81 $95,469 - $118,274
-9,233 Reduced 6.8%
126,572 $1.46 Million
Q4 2020

Feb 04, 2021
SELL
$8.61 - $11.04 $307,919 - $394,823
-35,763 Reduced 20.84%
135,805 $1.31 Million
Q3 2020

Nov 02, 2020
SELL
$8.57 - $12.69 $235,435 - $348,619
-27,472 Reduced 13.8%
171,568 $1.55 Million
Q1 2020

May 14, 2020
SELL
$6.69 - $13.45 $163,236 - $328,180
-24,400 Reduced 10.92%
199,040 $1.79 Million
Q4 2019

Jan 31, 2020
BUY
$6.53 - $10.72 $77,400 - $127,064
11,853 Added 5.6%
223,440 $2.19 Million
Q3 2019

Nov 04, 2019
BUY
$6.16 - $9.6 $1.05 Million - $1.64 Million
171,004 Added 421.37%
211,587 $1.46 Million
Q2 2019

Jul 24, 2019
BUY
$8.12 - $15.72 $42,223 - $81,744
5,200 Added 14.7%
40,583 $375,000
Q1 2019

Apr 26, 2019
SELL
$15.58 - $20.01 $645,167 - $828,614
-41,410 Reduced 53.92%
35,383 $555,000
Q4 2018

Feb 05, 2019
BUY
$14.59 - $23.84 $621,679 - $1.02 Million
42,610 Added 124.65%
76,793 $1.19 Million
Q3 2018

Nov 01, 2018
BUY
$21.06 - $25.65 $49,048 - $59,738
2,329 Added 7.31%
34,183 $736,000
Q2 2018

Jul 30, 2018
SELL
$16.77 - $24.71 $2.48 Million - $3.66 Million
-148,000 Reduced 82.29%
31,854 $775,000
Q1 2018

May 02, 2018
BUY
$16.68 - $22.07 $2.56 Million - $3.38 Million
153,354 Added 578.69%
179,854 $3.07 Million
Q3 2017

Nov 02, 2017
BUY
$15.41 - $32.17 $408,365 - $852,505
26,500
26,500 $466,000

Others Institutions Holding TEVA

# of Institutions
671
Shares Held
571M
Call Options Held
21.1M
Put Options Held
9.94M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email